ADAPTEK® TECHNOLOGY

ADAPTEK® TECHNOLOGY
Product Description

ADAPTEK® TECHNOLOGY is the general name for our 4 international patents and expertise in nanotechnology and controlled release systems.This is a transversal technology that allows to develop customized biopolymeric nanohydrogels, allowing the load with different API (drugs, vitamins, growth factors, etc.). These intelligent nanoparticles could be programmed to respond to external stimuli (E.g. pH or temperature) that allow the controlled release of APIs. 

Benefits for the client:
- Agile and efficient technology. Time to market reduction and cost saving production for industrial scaling.
- R&D injection. We maximize the value, efficacy and performance of active ingredients.- Differentiated, effective and innovative product that contribute new value to assets and increase of the unit profit margin.
- Vrio technology that brings competitive advantage in the market.
- Complete solution, adapted to your busines’ specific needs.

i+Med S. Coop.

  • ES
  • 2018
    On CPHI since
  • 3
    Certificates
  • 50 - 99
    Employees
Company types
Contract Service
Specifications

i+Med S. Coop.

  • ES
  • 2018
    On CPHI since
  • 3
    Certificates
  • 50 - 99
    Employees
Company types
Contract Service

More Products from i+Med S. Coop. (4)

  • OpHLINE - Ophthalmic Viscosurgical Devices (HA 1,4%/2%/3%)

    Product OpHLINE - Ophthalmic Viscosurgical Devices (HA 1,4%/2%/3%)

    OpHLINE is an ophthalmic viscosurgical devise (OVD) indicated as a coadjuvant during surgical procedures, involving the anterior chamber of the eye, especially in cataract surgery, including the extraction of the lens and the insertion of intraocular lenses.
    OpHLINE is available in 3 models ...
  • TrHLINE - Joint injections (linear HA 1%/2%)

    Product TrHLINE - Joint injections (linear HA 1%/2%)

    TrHLINE is a linear hyaluronic acid injection, designed for intra-articular administration to restore the viscoelastic properties of synovial fluid in traumatic and degenerative lesions of the joints, manifested by pain syndrome and reduced mobility.

    TrHLINE is available in 2 models with ...
  • TrHCROSS - Joint injections (cross-linked HA 2%)

    Product TrHCROSS - Joint injections (cross-linked HA 2%)

    TrHCROSS 2% is a biocompatible hydrogel of cross-linked sodium hyaluronate obtained by biofermentation. This is a single injection, designed to relieve joint pain in osteoarthritis by replacing natural joint fluid and replenishing lubricating and shock-absorbing functions.

    Properties
    ...
  • BtHLINE - Dermal filler for biorevitalization (linear HA 1,4%)

    Product BtHLINE - Dermal filler for biorevitalization (linear HA 1,4%)

    BtHLINE is a biocompatible linear hyaluronic acid hydrogel intended as a dermatologicaltreatment for aesthetic purposes. Administered by intradermal injection, the product is indicated to complement the extracellular matrix and intradermal tissue, restoring the anatomical structures of the skin, promot...

i+Med S. Coop. resources (2)

  • Brochure i+Med Company profile

    i+Med is a biotech company formed by highly qualified personnel, focused on the R&D and manufacture of new products for third parties. Our ADAPTEK® TECHNOLOGY enables the development of customized biopolymeric nanohydrogels, allowing the load with different API (drugs, vitamins, growth factors, etc.). These intelligent nanoparticles could be programmed to respond to external stimulus (E.g. pH or t˚) that allow the controlled release of APIs. As a result, we can develop high added value and differentiated products that provide our customers with a key competitive advantage in t...

  • Video Company video presentation

    i+Med is a company involved in the research, development and manufacture of new products in the field of biomedical engineering. 

     We specialize in the generation of intelligent Nanohydrogels and customized smart systems for controlled release adapted to the needs of each client, always under a strict control of the manufacturing process and a demanding quality policy.  
    More information at https://imasmed.com/en/